Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 17, 2018
Patent Application Number
15166306
Date Filed
May 27, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
In a first aspect, the present invention relates to genetically modified T-cells having a chimeric antigen receptor (CAR) in a method for adoptive cell therapy for treating TOSO+ cancer, like B-cell leukemia/lymphoma, in a subject in need thereof. In particular, the present invention relates to a genetically engineered T-cell containing and expressing a specific chimeric antigen receptor being toxic to TOSO+ cancer cells while being less toxic or non-toxic to TOSO+ non-cancer cells, in particular, being non-toxic to normal B cells and its precursors. In a further aspect, the present invention relates to a specific chimeric antigen receptor and the nucleic acid molecule encoding the same as well as vectors and cells containing the same.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
